Similar articles

• A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. AZTEC study group.

  Donnez J. Donnez J. Br J Obstet Gynaecol. 1999 Dec;106(12):1329. doi: 10.1111/j.1471-0528.1999.tb08195.x. Br J Obstet Gynaecol. 1999. PMID: 10609734 No abstract available.
• A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Minimally Invasive Surgical Techniques--Laser, EndoThermal or Endorescetion.

  Overton C, Hargreaves J, Maresh M. Overton C, et al. Br J Obstet Gynaecol. 1997 Dec;104(12):1351-9. doi: 10.1111/j.1471-0528.1997.tb11003.x. Br J Obstet Gynaecol. 1997. PMID: 9422012
• WITHDRAWN: Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.

  Sowter MC, Lethaby A, Singla AA. Sowter MC, et al. Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD001124. doi: 10.1002/14651858.CD001124.pub2. Cochrane Database Syst Rev. 2014. PMID: 25070909 Free PMC article.
• [Effects of GnGH agonists on menstrual and endometrial hormonal suppression in endometriosis. A review].

  Villarreal-Peral C, Juárez-Azpilcueta A, Piña-Ballesteros O, Romero-Hernández S, Motta-Martínez E. Villarreal-Peral C, et al. Ginecol Obstet Mex. 1996 Aug;64:352-5. Ginecol Obstet Mex. 1996. PMID: 8925985 Review. Spanish. No abstract available.
• Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.

  Bergquist C, Nillius SJ, Wide L, Lindgren A. Bergquist C, et al. Fertil Steril. 1981 Sep;36(3):339-42. doi: 10.1016/s0015-0282(16)45735-3. Fertil Steril. 1981. PMID: 6793403